Alts
- FUNDINGFUNDING · 1 min
Kotak Alts earns ₹1,650 crore from HKR Roadways sale, doubling investment
Kotak Alternate Asset Managers Ltd (Kotak Alts) has earned ₹1,650 crore from the sale of HKR Roadways, marking a twofold return on its investment.
09 Sept, 01:28 pm IST - STARTUPSSTARTUPS · 1 min
Biotech Startup Cellogen Therapeutics Raises ₹20 Cr from Kotak Alts
Cellogen Therapeutics has closed a ₹20 crore Series A round led by Kotak Alternate Asset Managers, the biotech startup disclosed on 12 June according to in…
18 May, 05:31 pm IST - FUNDING · BIOTECHFUNDING · BIOTECH · 3 min
Kotak Alts pumps ₹20 Cr into Cellogen Therapeutics for India cell-therapy push
₹20 Cr round will fund preclinical studies and IP build-out; Kotak Alts eyes India’s $10 Bn biotech opportunity
18 May, 04:34 pm IST